Helius Medical Technologies, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE: Pantera Entities Adjust Solana Stake
Pantera Capital entities have amended their Schedule 13D filing to reflect an adjustment in their beneficial ownership of Solana Company's Class A Common Stock following a warrant exercise.
NASDAQ
Choon Wee Chee, Executive Chairman of Solana Company, has increased his beneficial ownership to 20.2% following the settlement of restricted stock units.
NASDAQ
Fusion Summer Limited, controlled by Executive Chairman CHEE Choon Wee, acquired 17.0% of Helius Medical Technologies' Class A Common Stock for approximately $47.0 million.
NASDAQ
Pantera Capital and its founder Daniel W. Morehead have disclosed a significant 9.67% beneficial ownership stake in Helius Medical Technologies, Inc., including common stock and pre-funded warrants.